Investment Companies Roundup – October 2020
Source: RNS
Investment Companies Roundup - October 2020
As part of our commitment to providing free investment research, we have just published our regular monthly update on the listed Investment Companies sector.
Content
· Performance - Japanese funds shone brightest over a month where the hitherto technology-led rally took a pause. Biotech and healthcare funds continued to fare well, with the outcome of the US presidential election not expected to significantly affect healthcare policy.
· Discounts/premiums - In price terms, BlackRock Income and Growth has been the second-best performing UK equity income fund, over the year to date.
· Money in and out - The market for new issues returned with a vengeance, with several funds hoping to launch. They include Buffetology Smaller Companies, Home REIT, and Mailbox REIT.
· Major news stories - Temple Bar appointed RWC Asset Management, while also confirming its decision to stick with a value style.
Read full report here:
https://quoteddata.com/research/quoteddatas-investment-companies-roundup-october-2020/
Please also subscribe to our free sector and listed company research at our website and to alter your research preferences: http://bit.ly/2govJ07
QuotedData provides you access to research on investment companies. We're looking for ways to interact with our readers to a greater extent. Hopefully we'll meet you soon as we continue to travel around the UK with companies and also make educational sector trips with our analysts.
QUOTEDDATA
123a Kings Road | London SW3 4PL
Tel: +44 (0) 20 3691 9430
research@quoteddata.com | www.martenandco.com | www.quoteddata.com
NB: this note has been prepared by Marten & Co and is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
